Brand: Landmark Research

CapsuleNon-Nutrient/Non-BotanicalOn Market
Click to view full label

Net Contents

60 Capsule(s)

Serving Size

2 Capsule(s)

Servings Per Container

30

Supplement Form

Capsule

Bar Code (UPC/SKU)

Not specified

Product Version

Not Present

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

1Active Ingredients

Single-ingredient formula listed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 2 Capsule(s)

IngredientAmount Per Serving
Ibutamorin MK-067725 mg

Not Present

Other Ingredients

GelatinSilicaMagnesium Stearate

Target Groups

Adult (18 - 50 Years)

Label Claims

No Claim

Formulation

Formula re: Contains

Growth hormone & IGF secretgogue

Formulation re: Other

Research SARMS

Manufacturer & Distributor

Manufacturer

Landmark Research

Market Reference

$69.99· 1 listing
  • Hardcore Formulations Ibutamorin (Buy 2 Get 1 Free)

    MMAOverload.com
    $69.99Lowest

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • SUN-658 Ibutamoren Mesylate, an Oral Growth Hormone (GH) Secretagogue, Modifies Body Composition in Healthy Older Adults by Increasing Both the Amount and …

    A Roslan, R Nass, P Veldhuis… - Journal of the …, 2025 - academic.oup.com

    … This study uses FPCA to assess the effect of the first 6 months of treatment with IB in adults on the relationship between change in FFM and patterns of GH secretion in 12hr day-time …

    2025
  • Growth hormone secretagogues as potential therapeutic agents to restore growth hormone secretion in older subjects to those observed in young adults

    RG Smith, MO Thorner - The Journals of Gerontology: Series A, 2023 - academic.oup.com

    … ibutamoren treatment but the 2 studies differed in the selection of the study participants; the ibutamoren study selected healthy … their health status while the capromorelin study selected …

    202313 citations
  • Growth Hormone Secretagogues: Complete Class Guide-GHRPs, GHRH Analogs & Combination Protocols

    SF Assessment - formblends.com

    … The landmark clinical study of CJC-1295 … MK-677's effects on bone turnover markers in healthy elderly adults and functionally impaired elderly subjects. The study found that MK-677 25 …

  • The safety and efficacy of growth hormone secretagogues

    JT Sigalos, AW Pastuszak - Sexual medicine reviews, 2018 - academic.oup.com

    … have marketed ibutamoren and GHRPs as supplements, and … study, eight healthy young volunteers were calorically restricted for 14 days and for the last 7 days were given ibutamoren …

    201893 citations
  • Role of hormones in the pathogenesis and management of sarcopenia

    HK Kamel, D Maas, EH Duthie Jr - Drugs & aging, 2002 - Springer

    … The landmark study in this regard was published by Rudman … GH supplementation over a 6-month period in 21 healthy men … In this study, once-daily administration of oral ibutamoren 25 …

    2002181 citations
  • The Endocrine Society 2013 Laureate Awards

    MO Thorner - Mol Endocrinol, 2013 - academic.oup.com

    … study of 65 healthy older men and women was completed. Daily administration of MK-677 … and clinical research scientist in the field of endocrinology with landmark contributions to the …

    2013

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2019-12-22. DSLD Label ID: 209993. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.